205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.89%
Revenue growth 1.25-1.5x LSCC's 9.17%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
14.06%
Gross profit growth 1.25-1.5x LSCC's 10.62%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
32.73%
EBIT growth 50-75% of LSCC's 50.74%. Martin Whitman would suspect suboptimal resource allocation.
32.73%
Operating income growth at 50-75% of LSCC's 50.74%. Martin Whitman would doubt the firm’s ability to compete efficiently.
308.03%
Net income growth at 75-90% of LSCC's 356.01%. Bill Ackman would press for improvements to catch or surpass competitor performance.
316.22%
EPS growth at 75-90% of LSCC's 381.69%. Bill Ackman would push for improved profitability or share repurchases to catch up.
316.67%
Diluted EPS growth at 75-90% of LSCC's 381.69%. Bill Ackman would expect further improvements in net income or share count reduction.
-2.02%
Share reduction while LSCC is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.98%
Reduced diluted shares while LSCC is at 10.15%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.07%
Dividend reduction while LSCC stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
14.72%
OCF growth under 50% of LSCC's 251.07%. Michael Burry might suspect questionable revenue recognition or rising costs.
77.85%
FCF growth 75-90% of LSCC's 96.58%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
50.46%
10Y revenue/share CAGR above 1.5x LSCC's 1.57%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
109.30%
Positive 5Y CAGR while LSCC is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
75.93%
3Y revenue/share CAGR above 1.5x LSCC's 5.30%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
278.11%
Positive long-term OCF/share growth while LSCC is negative. John Neff would see a structural advantage in sustained cash generation.
25.75%
Below 50% of LSCC's 181.05%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
88.16%
Positive 3Y OCF/share CAGR while LSCC is negative. John Neff might see a big short-term edge in operational efficiency.
2966.45%
Positive 10Y CAGR while LSCC is negative. John Neff might see a substantial advantage in bottom-line trajectory.
1497.30%
5Y net income/share CAGR above 1.5x LSCC's 153.46%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2095.75%
3Y net income/share CAGR above 1.5x LSCC's 111.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
191.78%
10Y equity/share CAGR above 1.5x LSCC's 26.37%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
16.42%
Positive 5Y equity/share CAGR while LSCC is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
30.08%
Positive short-term equity growth while LSCC is negative. John Neff sees a strong advantage in near-term net worth buildup.
42.42%
Dividend/share CAGR of 42.42% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
46.49%
Dividend/share CAGR of 46.49% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
41.39%
3Y dividend/share CAGR of 41.39% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
7.29%
AR growth is negative/stable vs. LSCC's 30.15%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.14%
Inventory growth well above LSCC's 11.20%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.46%
Asset growth above 1.5x LSCC's 0.95%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
16.14%
BV/share growth above 1.5x LSCC's 0.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-86.48%
We’re deleveraging while LSCC stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.56%
R&D growth drastically higher vs. LSCC's 0.01%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.71%
We cut SG&A while LSCC invests at 9.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.